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5.3 Valorisation
There are ample reasons to study rare diseases such as the Mendelian disorders of 
cornification (MEDOC) and the clinical and genetic heterogeneity in MEDOC. First of 
all, people have them; they are affected by and suffer from MEDOC. Without research 
on the clinical and pathophysiologic aspects of their disease, it is impossible to deliver 
appropriate care to these patients. The low prevalence of MEDOC is not an argument 
to ignore the needs of these patients. Secondly, the study of MEDOC grants us insight 
in fundamental principles of epidermal functioning. Our knowledge of skin disease is 
severely limited, mostly because we understand very little about how normal human 
skin works. By studying the models that nature is offering us, we might attain some 
comprehension. This understanding may be helpful, in a strict sense, in the development 
of refined diagnostic strategies and (targeted) therapies for MEDOC. In a broader sense, 
the extent of the expanding comprehension of epidermal homeostasis may reach as 
far as areas as the pathophysiology of non-genetic, multifactorial and more common 
skin diseases such as auto-immune blistering disorders, psoriasis or wound healing. 
Thirdly, the value of describing clinical and genetic variability lies mainly in the field of 
patient management: our study provides tools to dermatologists and clinical geneticist 
that will hopefully improve diagnosis and treatment of MEDOC. Lastly, fundamental 
research or research without direct apparent benefits for large numbers of individuals 
is valuable by itself.   
The disease burden of MEDOC. MEDOC are rare diseases with few individuals 
affected in absolute numbers, but the lives of patients are influenced in a profound way. 
In this regard, MEDOC patients differ from the general dermatological population. Skin 
diseases are a significant health problem. The disease burden of dermatologic disorders 
is high in the general population: all skin conditions combined were the fourth leading 
cause of non-fatal disease burden at the global level84,85. However, this is mainly due to 
the high prevalence of dermatologic disease. The disability rate of most skin diseases 
is relatively low84,85. The opposite is the case for MEDOC. These skin diseases are rare 
– the reported prevalence for DD is 1:30,000-100,00086, for EI 1:200,00087,88 and for 
MDM <1:1,000,000 (estimated1) – but they have a significant impact on health related 
quality of life (HRQL). Several studies identified a substantial impairment of quality 
of life in patients with DD55,89, HHD89,90 and EI62-64. Furthermore, the mean health 
care related costs associated with congenital ichthyosis, among which EI, is estimated 
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at $3,192 per annum62,91. Up to 30% of these costs is borne out of pocket by patients. 
Although no cost analysis studies have been performed for DD, HHD and MDM, it can 
be expected that these costs may be in the same order of magnitude as for ichthyosis. 
Research efforts and improving knowledge are important steps in optimizing care and 
treatment to alleviate the burden of patients with MEDOC and reduce health care costs 
for patients and society.
The advancement of our understanding of the skin. The study of these disorders has 
provided much insight in epidermal homeostasis. In the past two decades, almost all 
MEDOC have been linked to defects in various proteins associated with keratinocyte 
function and differentiation. The prevailing view on epidermal physiology was the 
“bricks and mortar”-model. Improper functioning of structural proteins due to 
mutations in their coding genes was thought to impair either the keratinocytes (bricks) 
or proteins connecting the keratinocytes (mortar). The discovery of defects in genes 
encoding structural proteins such as keratin 1, causing EI, supported this view. With 
the discovery of mutations in ATP2A2, ATP2C1 and SLURP1 as the cause of DD, HHD 
and Mal de Meleda (MDM) respectively, the “brick and mortar”-model proved to be 
an insufficient metaphor for epidermal homeostasis92. ATP2A2 and ATP2C1 encode 
intracellular calcium pumps and SLURP1 encodes a protein enhancing the function 
of an epidermal nicotinic receptor. These proteins are parts of signaling pathways 
that coordinate cell differentiation and underlie the crucial role of keratinocytes in 
skin integrity. Research on these pathways revealed complex networks of interacting 
signal molecules in keratinocytes, and defects of these proteins heavily impair proper 
epidermal differentiation and function. Patients with MEDOC provide a great 
opportunity to study the biological consequences of gene mutations affecting epidermal 
biology in humans. To study a human disease model of MEDOC would otherwise be 
impossible. 
Improvement of patient care. Diagnosis of MEDOC can sometimes be difficult, as we 
have shown in chapter III and IV for Epidermolytic Ichthyosis (EI), Darier disease (DD) 
or Hailey-Hailey disease (HHD). Research on MEDOC extends our understanding of 
the phenotype of these diseases and the disease course. This, in turn, helps physicians 
in their care for patients with a genodermatosis, which is often difficult. Treatment 
options are often limited, but almost all patients are helped significantly with a right 
diagnosis93,94. Making the right diagnosis often ends a period of doubt and uncertainty. 
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The physician therefore must be able to discriminate these rare diseases from more 
common skin ailments, and should be able to recognize atypical presentation of these 
diseases.  
